Publication | Closed Access

A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator

AngiogenesisRho KinaseHematologyPathologyHemostasisTissue Plasminogen ActivatorCell-matrix InteractionVascular BiologyMatrix BiologyMedicineCell BiologyMetalloproteinase-9-related Hemorrhagic TransformationExtracellular MatrixConnective Tissue Disease